Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee Ratner

Showing results (51-60 of 145) with videos related to

Pageof 15
Sort By:
ACS Nano|September 24, 2013
Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptidesKirk K Hou, Hua Pan, Lee Ratner, et al.
Antiviral Therapy|September 8, 2012
Cytolytic nanoparticles attenuate HIV-1 infectivityJoshua L Hood, Andrew P Jallouk, Nancy Campbell, et al.
Virology|December 9, 2008
Mutation of critical serine residues in HIV-1 matrix result in an envelope incorporation defect which can be rescued by truncation of the gp41 cytoplasmic tailAjay K Bhatia, Rajnish Kaushik, Nancy A Campbell, et al.
Nanomaterials (Basel, Switzerland)|July 2, 2021
Targeting NF-κB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia/LymphomaDaniel A Rauch, John C Harding, Lee Ratner, et al.
Journal of Virology|March 30, 2004
Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversionLee R Silverman, Andrew J Phipps, Andrew Montgomery, et al.
Retrovirology|July 20, 2007
Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survivalAntara Datta, Lee Silverman, Andrew J Phipps, et al.
Journal of Virology|February 22, 2019
V1 and V2 Domains of HIV Envelope Contribute to CCR5 Antagonist ResistanceEllen Wu, Yueqi Du, Xiang Gao, et al.
Virology|August 8, 2006
Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activityBindhu Michael, Amrithraj M Nair, Antara Datta, et al.
AIDS Research and Human Retroviruses|January 25, 2005
Cholesterol dependence of HTLV-I infectionMatthew M Wielgosz, Daniel A Rauch, Kathryn S Jones, et al.
Blood|August 25, 2005
HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibitionLing Gao, Hongju Deng, Haibo Zhao, et al.
Pageof 15

Showing results (51-60 of 145) with videos related to

Sort By:
Pageof 15
ACS Nano|September 24, 2013
Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptidesKirk K Hou, Hua Pan, Lee Ratner, et al.
Antiviral Therapy|September 8, 2012
Cytolytic nanoparticles attenuate HIV-1 infectivityJoshua L Hood, Andrew P Jallouk, Nancy Campbell, et al.
Virology|December 9, 2008
Mutation of critical serine residues in HIV-1 matrix result in an envelope incorporation defect which can be rescued by truncation of the gp41 cytoplasmic tailAjay K Bhatia, Rajnish Kaushik, Nancy A Campbell, et al.
Nanomaterials (Basel, Switzerland)|July 2, 2021
Targeting NF-κB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia/LymphomaDaniel A Rauch, John C Harding, Lee Ratner, et al.
Journal of Virology|March 30, 2004
Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversionLee R Silverman, Andrew J Phipps, Andrew Montgomery, et al.
Retrovirology|July 20, 2007
Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survivalAntara Datta, Lee Silverman, Andrew J Phipps, et al.
Journal of Virology|February 22, 2019
V1 and V2 Domains of HIV Envelope Contribute to CCR5 Antagonist ResistanceEllen Wu, Yueqi Du, Xiang Gao, et al.
Virology|August 8, 2006
Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activityBindhu Michael, Amrithraj M Nair, Antara Datta, et al.
AIDS Research and Human Retroviruses|January 25, 2005
Cholesterol dependence of HTLV-I infectionMatthew M Wielgosz, Daniel A Rauch, Kathryn S Jones, et al.
Blood|August 25, 2005
HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibitionLing Gao, Hongju Deng, Haibo Zhao, et al.
Pageof 15